598 related articles for article (PubMed ID: 28589498)
1. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
[TBL] [Abstract][Full Text] [Related]
2. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
Yacob O; Umer M; Gul M; Qadir I
J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the risk factors for local recurrence of giant cell tumor of long bone].
Xu H; Niu X
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):465-8. PubMed ID: 25241792
[TBL] [Abstract][Full Text] [Related]
4. [Case analysis on treatment and recurrence of giant cell tumor of bone].
Zhang Z; Zhu B; Sun T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
[TBL] [Abstract][Full Text] [Related]
5. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
[TBL] [Abstract][Full Text] [Related]
6. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for recurrence of giant cell tumours of bone.
Siddiqui MA; Seng C; Tan MH
J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
Li X; Guo W; Yang Y; Wei R; DU ZY
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
[TBL] [Abstract][Full Text] [Related]
9. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
10. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
11. Giant cell tumor of bone: oncological and functional results of long-term follow-up.
Oda Y; Miura H; Tsuneyoshi M; Iwamoto Y
Jpn J Clin Oncol; 1998 May; 28(5):323-8. PubMed ID: 9703860
[TBL] [Abstract][Full Text] [Related]
12. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
[TBL] [Abstract][Full Text] [Related]
13. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
[TBL] [Abstract][Full Text] [Related]
14. The outcomes of treatment of giant cell tumor of bone around the knee.
Asavamongkolkul A; Eamsobhana P; Waikakul S; Phimolsarnti R
J Med Assoc Thai; 2012 Sep; 95 Suppl 9():S122-8. PubMed ID: 23326994
[TBL] [Abstract][Full Text] [Related]
15. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
[TBL] [Abstract][Full Text] [Related]
16. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
[TBL] [Abstract][Full Text] [Related]
17. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?
Wysocki RW; Soni E; Virkus WW; Scarborough MT; Leurgans SE; Gitelis S
Clin Orthop Relat Res; 2015 Feb; 473(2):706-15. PubMed ID: 25472928
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of giant cell tumors with pathological fracture around the knee].
Liu WF; Yang FJ; Li Y; Li B; Hao L; Niu XH
Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):677-686. PubMed ID: 30157574
[No Abstract] [Full Text] [Related]
20. [Meta-analysis of risk factors of recurrence in patients with giant cell tumor on extremities].
Li R; Hu Y
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(47):3778-83. PubMed ID: 25623108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
